Sandbox:lipid: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
{{familytree | | | | | | | | | | | | | | | F01 | | | | F02 | F01='''Type A:'''<br> [[Familial hypercholesterolemia]]| F02= '''Type B:'''<br> [[Familial combined hyperlipidemia]]}}
{{familytree | | | | | | | | | | | | | | | F01 | | | | F02 | F01='''Type A:'''<br> [[Familial hypercholesterolemia]]| F02= '''Type B:'''<br> [[Familial combined hyperlipidemia]]}}
{{familytree/end}}
{{familytree/end}}
{| class="wikitable"
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=3  | {{fontcolor|#FFFFFF}}Functional Asseeement
|-
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1  | {{fontcolor|#FFFFFF}}Key Steps
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1  | {{fontcolor|#FFFFFF}}Essential Elements
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1  | {{fontcolor|#FFFFFF}}Additional Details
|-
|style="padding: 5px 5px; background: #F5F5F5;" |Frailty and Disability
|style="padding: 5px 5px; background: #F5F5F5;" |Symptoms
AS severity
|style="padding: 5px 5px; background: #F5F5F5;" |Intensity, acuity
Echo and other imaging
|-
|style="padding: 5px 5px; background: #F5F5F5;" |Baseline clinical data
|style="padding: 5px 5px; background: #F5F5F5;" |Cardiac history
Physical exam and labs
Chest irradiation
Dental evaluation
Allergies
Social support
|style="padding: 5px 5px; background: #F5F5F5;" | Prior cardiac interventions
Routine blood tests, [[PFTs]]
Access issues, other cardiac effects
Treat dental issues before TAVR
[[Contrast]], [[latex]], medications
Recovery, transportation, post discharge planning
|-
|style="background: #F5F5F5; padding: 5px 5px;" rowspan=6 colspan=1" | Major CV comorbidity
|style="background: #F5F5F5;|Coronary artery disease
|style="background: #F5F5F5;|[[Coronary angiography]]
|-
|style="background: #F5F5F5;|LV systolic dysfunction
|style="background: #F5F5F5;|[[LV ejection fraction]]
|-
|style="background: #F5F5F5;|Concurrent valve disease
|style="background: #F5F5F5;|Severe [[Mitral regurgitation|MR]] or [[Mitral stenosis|MS]]
|-
|style="background: #F5F5F5;|[[Pulmonary hypertension]]
|style="background: #F5F5F5;|Assess pulmonary pressures
|-
|style="background: #F5F5F5;|Aortic disease
|style="background: #F5F5F5;|Porcelain aorta (CT scan)
|-
|style="background: #F5F5F5;|Peripheral vascular disease
|style="background: #F5F5F5;|Prohibitive re-entry after previous open heart
surgery (CT scan)
Hostile chest
|-
| style="background: #F5F5F5; padding: 5px 5px;" rowspan=5 colspan=1" |Major non CV comorbidity
|style="background: #F5F5F5;|[[Malignancy]]
|style="background: #F5F5F5;|Remote or active, life expectancy
|-
|style="background: #F5F5F5;|Gastrointestinal and liver disease
|style="background: #F5F5F5;|[[IBD]], [[cirrhosis]], [[Esophageal varices|varices]], [[Gastrointestinal bleeding|GIB]], ability to take
antiplatelets/anticoagulation
|-
|style="background: #F5F5F5;|Kidney disease
|style="background: #F5F5F5;|[[eGFR]] <30cc/min or [[dialysis]]
|-
|style="background: #F5F5F5;|Pulmonary disease
|style="background: #F5F5F5;|Oxygen requirement, [[FEV1]] <50% predicted or
[[DLCO]]<50% predicted
|-
|style="background: #F5F5F5;|Neurological disorders
|style="background: #F5F5F5;|[[Movement disorder|Movement disorders]], [[dementia]]
|}

Revision as of 15:20, 11 January 2017


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lipid disorders
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypolipoproteinemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hyperlipoproteinemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary
 
 
 
 
Secondary
 
 
 
 
 
 
 
 
Primary
 
 
 
 
Secondary
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Low LDL
 
 
 
Low HDL
 
Anemia, Chronic inflammation, Chronic liver disease, Hyperthyroidism
Infection, Malabsorption, Malignancy, Criticial illness
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alcohol, Diabetes, Drugs
Liver disease, Obesity
Renal disease
Smoking, Hypothyroidism
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abetalipoproteinemia, Hypobetalipoproteinemia
PCSK9 deficiency, Chylomicron retention disease, Familial combined hypolipidemia
 
 
 
LCAT deficiency,
Apolipoprotein 1 deficiency,
Familial hypoalphalipoproteinemia,
Tangier disease, FISH eye disease, Familial combined hypolipidemia
 
 
 
Type I:
Familial hyperchylomicronemia
 
 
Type II
 
Type III:
Dysbetalipoproteinemia
 
Type IV:
Primary hypertriglyceridemia
 
Type V:
Mixed hyperlipoproteinemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type A:
Familial hypercholesterolemia
 
 
 
Type B:
Familial combined hyperlipidemia


Functional Asseeement
Key Steps Essential Elements Additional Details
Frailty and Disability Symptoms

AS severity

Intensity, acuity

Echo and other imaging

Baseline clinical data Cardiac history

Physical exam and labs

Chest irradiation

Dental evaluation

Allergies

Social support

Prior cardiac interventions

Routine blood tests, PFTs

Access issues, other cardiac effects

Treat dental issues before TAVR

Contrast, latex, medications

Recovery, transportation, post discharge planning

Major CV comorbidity Coronary artery disease Coronary angiography
LV systolic dysfunction LV ejection fraction
Concurrent valve disease Severe MR or MS
Pulmonary hypertension Assess pulmonary pressures
Aortic disease Porcelain aorta (CT scan)
Peripheral vascular disease Prohibitive re-entry after previous open heart

surgery (CT scan)

Hostile chest


Major non CV comorbidity Malignancy Remote or active, life expectancy
Gastrointestinal and liver disease IBD, cirrhosis, varices, GIB, ability to take

antiplatelets/anticoagulation

Kidney disease eGFR <30cc/min or dialysis
Pulmonary disease Oxygen requirement, FEV1 <50% predicted or

DLCO<50% predicted

Neurological disorders Movement disorders, dementia